Cargando…

A new role for statins in sepsis

Several studies have shown promising results regarding the use of statins as an adjunctive treatment for sepsis. Most of those studies were retrospective or observational in nature. The ASEPSIS trial has reported that the administration of atorvastatin reduced clinical progression of sepsis but did...

Descripción completa

Detalles Bibliográficos
Autores principales: Rachoin, Jean-Sebastien, Cerceo, Elizabeth, Dellinger, R Phillip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056163/
https://www.ncbi.nlm.nih.gov/pubmed/23324213
http://dx.doi.org/10.1186/cc11907
_version_ 1782320798529224704
author Rachoin, Jean-Sebastien
Cerceo, Elizabeth
Dellinger, R Phillip
author_facet Rachoin, Jean-Sebastien
Cerceo, Elizabeth
Dellinger, R Phillip
author_sort Rachoin, Jean-Sebastien
collection PubMed
description Several studies have shown promising results regarding the use of statins as an adjunctive treatment for sepsis. Most of those studies were retrospective or observational in nature. The ASEPSIS trial has reported that the administration of atorvastatin reduced clinical progression of sepsis but did not improve mortality. These findings are promising and further multicenter trials are needed to confirm these outcomes and to establish whether this class of medications will offer utility in this regard.
format Online
Article
Text
id pubmed-4056163
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40561632014-06-14 A new role for statins in sepsis Rachoin, Jean-Sebastien Cerceo, Elizabeth Dellinger, R Phillip Crit Care Commentary Several studies have shown promising results regarding the use of statins as an adjunctive treatment for sepsis. Most of those studies were retrospective or observational in nature. The ASEPSIS trial has reported that the administration of atorvastatin reduced clinical progression of sepsis but did not improve mortality. These findings are promising and further multicenter trials are needed to confirm these outcomes and to establish whether this class of medications will offer utility in this regard. BioMed Central 2013 2013-01-17 /pmc/articles/PMC4056163/ /pubmed/23324213 http://dx.doi.org/10.1186/cc11907 Text en Copyright © 2013 BioMed Central Ltd
spellingShingle Commentary
Rachoin, Jean-Sebastien
Cerceo, Elizabeth
Dellinger, R Phillip
A new role for statins in sepsis
title A new role for statins in sepsis
title_full A new role for statins in sepsis
title_fullStr A new role for statins in sepsis
title_full_unstemmed A new role for statins in sepsis
title_short A new role for statins in sepsis
title_sort new role for statins in sepsis
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056163/
https://www.ncbi.nlm.nih.gov/pubmed/23324213
http://dx.doi.org/10.1186/cc11907
work_keys_str_mv AT rachoinjeansebastien anewroleforstatinsinsepsis
AT cerceoelizabeth anewroleforstatinsinsepsis
AT dellingerrphillip anewroleforstatinsinsepsis
AT rachoinjeansebastien newroleforstatinsinsepsis
AT cerceoelizabeth newroleforstatinsinsepsis
AT dellingerrphillip newroleforstatinsinsepsis